Smad6 negatively regulates interleukin 1-receptor Toll-like receptor signaling through direct interaction with the adaptor Pellino-1

被引:112
作者
Choi, Kyung-Chul
Lee, Youn Sook
Lim, Seunghwan
Choi, Hyo Kyoung
Lee, Chang-Hun
Lee, Eun-Kyung
Hong, Suntaek
Kim, In-Hoo
Kim, Seong-Jin
Park, Seok Hee [1 ]
机构
[1] Inha Univ, Coll Med, Dept Pathol, BK Project 21,Ctr Adv Med Educ, Inchon 400712, South Korea
[2] Inha Univ, Coll Med, Inha Res Inst Med Sci, Inchon 400712, South Korea
[3] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA
[4] Natl Canc Ctr, Res Inst, Goyang 411769, Gyeonggi, South Korea
关键词
D O I
10.1038/ni1383
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transforming growth factor-beta 1 (TGF-beta 1) is a potent cytokine with pleiotropic effects, including anti-inflammatory activity. Here we show that the signaling protein Smad6 bound to Pellino-1, an adaptor protein of mammalian interleukin 1 receptor (IL-1R) associated kinase 1 ( IRAK1), and thereby promoted TGF-beta-mediated anti-inflammatory effects. Smad6-Pellino-1 interaction abrogated signaling mediated by a complex of IRAK1, Pellino-1 and adaptor protein TRAF6 that formed after stimulation by IL-1 beta treatment. Blockade of IRAK1-Pellino-1-TRAF6 signaling prevented degradation of the inhibitor I kappa B alpha and subsequent nuclear translocation of transcription factor NF-kappa B and thus expression of proinflammatory genes. 'Knockdown' of endogenous Smad6 expression by RNA interference reduced anti-inflammatory activity mediated by TGF-beta 1 or the TGF-beta family member BMP-4. Thus Smad6 is a critical mediator of the TGF-beta-BMP pathway that mediates anti-inflammatory activity and negatively regulates IL-1R-Toll-like receptor signals.
引用
收藏
页码:1057 / 1065
页数:9
相关论文
共 56 条
[1]   Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members [J].
Afrakhte, M ;
Morén, A ;
Jossan, S ;
Itoh, S ;
Westermark, B ;
Heldin, CH ;
Heldin, NE ;
ten Dijke, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) :505-511
[2]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[3]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[4]   Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts [J].
Asano, Y ;
Ihn, H ;
Yamane, K ;
Kubo, M ;
Tamaki, K .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (02) :253-264
[5]   Smad6 as a transcriptional corepressor [J].
Bai, ST ;
Shi, XM ;
Yang, XL ;
Cao, X .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8267-8270
[6]   A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-β signaling [J].
Bai, ST ;
Cao, X .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) :4176-4182
[7]  
Bitzer M, 2000, GENE DEV, V14, P187
[8]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[9]   ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance [J].
Brint, EK ;
Xu, DM ;
Liu, HY ;
Dunne, A ;
McKenzie, ANJ ;
O'Neill, LAJ ;
Liew, FY .
NATURE IMMUNOLOGY, 2004, 5 (04) :373-379
[10]   Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 [J].
Burns, K ;
Janssens, S ;
Brissoni, B ;
Olivos, N ;
Beyaert, R ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :263-268